Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways inbr / high-grade myelodysplastic syndrome
Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways inbr / high-grade myelodysplastic syndrome
复制标题
Rigosertib 作为选择性抗肿瘤药物可以改善重度骨髓增生异常综合征中多种失调的信号转导途径
作者：
刘立;史文慧;朱杨;赵佑山;顾树程;费成明;郭娟;吴东;周立宇
